Delivery Order SPE2DB24D2205-SPE2DB25FEHCL
Award Date 9/4/25
Potential Completion Date 9/5/25
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) with a ceiling value of $1,228.36. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procurement procedures. The order is set for ultimate completion on August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Vyvanse 40 mg capsules (quantity: 100s) with a contract value of $3,121.30 and an ultimate completion date of July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Vyvanse 30 mg capsules (100-count units) with a ceiling value of $2,675.40. This competitively awarded, firm fixed-price delivery order is set to be completed by July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Vyvanse 40 mg capsules (100 count) valued at $1,461.68. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the company's demonstrated capability to compete...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) with a contract value of $1,965.56 and an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) with a contract value of $2,971.21. This competitively awarded, firm fixed-price delivery order is set to be completed by September 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) with a ceiling value of $5,279.97. This is a firm fixed price delivery order issued under a child contract mechanism, with performance to be completed by September 3, 2025, and fulfillment originating from the vendor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating the contract was...
- The Defense Logistics Agency awarded a $1,413.54 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Vyvanse 30 mg capsules (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 5, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Vyvanse 40 mg capsules (100 count) with a ceiling value of $1,253.12. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, on August 7, 2025, for the supply of Vyvanse 40 mg capsules (100 count). This competitively awarded, non-set-aside contract carries a ceiling value of $1,161.44 with firm fixed pricing and a completion date of August 8, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical...